- BTCP HCL
-
- $0.00 / 1gram
-
2022-02-18
- CAS:112726-66-6
- Min. Order: 1gram
- Purity: 99%
- Supply Ability: 10kg
|
| BTCP HCL Basic information |
Product Name: | BTCP HCL | Synonyms: | BTCP HCL;1-(1-benzo(b)thien-2-ylcyclohexyl)-piperidin;1-(1-benzo(b)thien-2-ylcyclohexyl)piperidine;gk13;BTCP HYDROCHLORIDE POTENT & SELECTIVE DO;1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine;N-[1-(Benzo[b]thien-2-yl-cyclohexyl)]piperidine hydrochloride;1-(1-Benzo[b]thiophen-2-ylcyclohexyl)piperidine | CAS: | 112726-66-6 | MF: | C19H25NS | MW: | 299.47 | EINECS: | | Product Categories: | | Mol File: | 112726-66-6.mol | |
| BTCP HCL Chemical Properties |
Melting point | 80℃ (ethanol ) | Boiling point | 425.4±20.0 °C(Predicted) | density | 1.135±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | H2O: >180 mg/mL | form | solid | pka | 8.56±0.20(Predicted) | color | white |
RIDADR | UN 2811 6.1/PG 2 | WGK Germany | 3 | Toxicity | mouse,LD,intraperitoneal,> 100mg/kg (100mg/kg),United States Patent Document. Vol. #5248686, |
| BTCP HCL Usage And Synthesis |
Uses | Benzothiophenylcyclohexylpiperidine Maleate is a potent dopamine re-uptake/transport inhibitor different from PCP and other stimulants. | Definition | ChEBI: A tertiary amino compound that consists of cyclohexane having piperidin-1-yl and benzothiophen-2-yl groups attached at position 1. A potent dopamine re-uptake inhibitor with a behavioral profile different from that of phencyclidine (PCP) and similar to tha
of cocaine. | Biological Activity | A potent dopamine re-uptake inhibitor with a behavioral profile different from that of PCP and similar to that of cocaine. | references | [1] vignon j, pinet v, cerruti c, et al. [3h] n-[1-(2-benzo (b) thiophenyl) cycohexyl] piperidine ([3h] btcp): a new phencyclidine analog selective for the dopamine uptake complex[j]. european journal of pharmacology, 1988, 148(3): 427-436. [2] chaudieu i, vignon j, chicheportiche m, et al. role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by pcp analogs[j]. pharmacology biochemistry and behavior, 1989, 32(3): 699-705. [3] seeman p. brain dopamine receptors[j]. pharmacological reviews, 1980, 32(3): 229-313. [4] maurice t, vignon j, kamenka j m, et al. in vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3 h] btcp[j]. neuroscience letters, 1989, 101(2): 234-238. |
| BTCP HCL Preparation Products And Raw materials |
|